Virtus ETF Advisers LLC Zoetis Inc. Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$151.44 - $200.09 $531,402 - $702,115	3,509 New	3,509 $692,000
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $46,414 - $57,138	-313 Reduced 7.68%	3,762 $558,000
Q2 2022 Aug 12, 2022	BUY	$155.97 - $200.09 $635,577 - $815,366	4,075 New	4,075 $700,000
Q4 2019 Feb 13, 2020	SELL	$116.25 - $133.25 $17,553 - $20,120	-151 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$112.57 - $128.43 $16,998 - $19,392	151 New	151 $19,000

1,951

408M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $78.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.